https://doi.org/10.55788/878c93c8
Dr Amani Beshara (Hillel Yaffe Medical Center, Israel) and colleagues evaluated the value of colonoscopies in assessing constipation in young women [1]. The multicentre, cross-sectional study identified 377,795 individuals undergoing colonoscopy, 52.6% women and 47.4% men. Cohort 1 included 7,872 women who underwent colonoscopy for constipation along with other indications, while cohort 2 comprised 6,852 women who underwent colonoscopy for constipation only.
In cohort 1, 1,017 women were between 18 and 39. Three-quarters of these young women (74.8%) had a normal colonoscopy. The authors found that 1.2% had ulcerative colitis, 0.7% had Crohnâs disease, and 7.4% had colonic polyps. Young men undergoing colonoscopy for constipation and other indications had a higher rate of colonic polyps (11.3% vs 7.4%; P=0.011).
Analysing the data from the 807 women between 18 and 39 years of age in cohort 2, the investigators reported comparable results: 75.3% had a normal colonoscopy, the ulcerative colitis rate was 0.7%, the Crohnâs disease rate was 0.2%, and the polyps of the colon rate 8.1%. âIn cohort 2, the findings in young women were comparable with those in young men,â added Dr Beshara.
âThus, the diagnostic yield of colonoscopy for isolated constipation in women under 40 appears limited,â concluded Dr Beshara.
- Beshara A, et al. Yield of colonoscopy in evaluation young women with constipation. LB15, UEG Week 2024, 12â15 October, Vienna, Austria.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« Tradipitant improves symptoms of motion sickness Next Article
Guar gum alleviates IBS-related constipation in a randomised controlled trial »
« Tradipitant improves symptoms of motion sickness Next Article
Guar gum alleviates IBS-related constipation in a randomised controlled trial »
Table of Contents: UEGW 2024
Featured articles
Cendakimab meets primary endpoints in eosinophilic oesophagitis
IBD: New Drugs, Established Agents, and Prevention
LOVE-CD: Vedolizumab yields better outcomes in early than in late CD
Moving towards the prevention of IBD
New insights into perianal fistulising CD pathogenesis may lead to new therapies
Risankizumab influences key pathogenic Th17 cells in CD
Meaningful corticosteroid-sparing effect of mirikizumab in UC
Extending ustekinumab dosing interval does not influence drug survival in IBD
CULTIVATE: Promising signal for etrasimod in Crohnâs disease
Tamuzimod delivers promising long-term data in UC
TL1A inhibitor tulisokibart shows potential in UC
Upadacitinib associated with normalisation of HRQoL in UC
Pancreas: Improved Diagnostics and Treatment Algorithms
Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA
An accelerated treatment approach may save lives in pancreatic walled-off necrosis
Irritable Bowel Syndrome: from Guar Gum to Tradipitant
Guar gum alleviates IBS-related constipation in a randomised controlled trial
How useful is colonoscopy for constipation in young women?
Liver: Exploring New Therapeutics
Encouraging results for L-carnitine in metabolic dysfunction-associated steatotic liver disease
Other Late-breaking Studies from UEGW
TACITO: Does faecal microbiota transplantation improve survival in mRCC?
Is faecal microbiota transplantation a viable option to treat primary C. difficile infections?
Cendakimab meets primary endpoints in eosinophilic oesophagitis
Related Articles
September 10, 2021
Sleeve gastrectomy has higher GERD risk than gastric bypass
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com